← SkinHealth Systems Inc.
| Annual Trend | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|
| Cash, cash equivalents, and restricted cash | $3.3m | $901.9m | $568.2m | $523.0m | $370.1m | $232.7m | |
| Accounts receivable, net of allowances for estimated credit losses of $6,022 and $9,597 at December 31, 2025 and December 31, 2024, respectively | $18.6m | $46.8m | $76.5m | $54.7m | $27.6m | $21.7m | |
| Inventories | $23.2m | $35.3m | $116.4m | $91.3m | $69.1m | $48.0m | |
| Income tax receivable | $4.6m | $4.6m | $1.3m | $332k | $818k | $1.7m | |
| Prepaid expenses and other current assets | $3.2m | $12.3m | $26.7m | $28.9m | $9.5m | $5.4m | |
| Total current assets | $3.9m | $1.0b | $789.1m | $698.3m | $477.1m | $309.5m | |
| Property and equipment, net | $9.2m | $16.2m | $18.2m | $14.2m | $6.0m | $2.5m | |
| Intangible assets, net | $50.9m | $56.0m | $46.4m | $62.1m | $47.5m | $35.8m | |
| Goodwill | $98.5m | $123.7m | $124.6m | $125.8m | $123.5m | $126.6m | |
| Right-of-use assets, net | $0 | $15.0m | $15.6m | $12.1m | $13.6m | $11.6m | |
| Other assets | $4.8m | $6.7m | $14.2m | $16.0m | $14.1m | $11.9m | |
| Deferred income tax assets, net | $270k | $330k | $815k | $531k | $3.9m | $1.9m | |
| Current portion of convertible senior notes, net | — | — | — | — | $0 | $124.0m | |
| Lease liabilities, current | $0 | $3.7m | $5.0m | $4.6m | $5.1m | $5.1m | |
| Income tax payable | $0 | $292k | $962k | $2.8m | $3.4m | $1.2m | |
| Lease liabilities, non-current | $0 | $12.8m | $12.7m | $9.3m | $10.8m | $9.2m | |
| Convertible senior notes, net | $0 | $729.9m | $734.1m | $738.4m | $552.2m | $240.4m | |
| Total stockholders’ equity | $5.0m | $302.3m | $171.5m | $59.4m | $51.8m | $61.1m | |
| TOTAL ASSETS | $464.0m | $1.2b | $1.0b | $929.1m | $685.7m | $499.8m | |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $464.0m | $1.2b | $1.0b | $929.1m | $685.7m | $499.8m | |
| Accounts payable | $18.5m | $29.0m | $30.3m | $44.8m | $21.9m | $15.6m | |
| Accrued payroll-related expenses | $12k | $28.7m | $21.7m | $22.0m | $17.6m | $24.9m | |
| Other accrued expenses | $754k | $14.7m | $15.2m | $19.8m | $20.0m | $15.4m | |
| Total current liabilities | $765k | $76.4m | $73.1m | $115.0m | $68.2m | $186.3m | |
| Deferred income tax liabilities, net | $4.0m | $3.6m | $2.0m | $702k | $396k | $393k | |
| Other long-term liabilities | $1.9m | $0 | $0 | $2.8m | $1.8m | $2.4m | |
| Total liabilities | $16.9m | $916.5m | $837.4m | $869.7m | $633.9m | $438.7m | |
| Class A Common Stock, $0.0001 par value; 320,000,000 shares authorized; 127,520,823 and 124,924,185 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | 1k | 16k | 14k | 12k | 12k | 13k | |
| Additional paid-in capital | $6.1m | $722.2m | $550.3m | $541.3m | $566.7m | $580.0m | |
| Accumulated other comprehensive loss | $242k | ($1.3m) | ($4.5m) | ($3.0m) | ($7.0m) | ($1.4m) | |
| Accumulated deficit | ($1.1m) | ($418.7m) | ($374.3m) | ($478.9m) | ($508.0m) | ($517.5m) |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.